Insider Trading & Ownership - ROBERTSON MICHELLE

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ROBERTSON MICHELLE
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-05-11
Sale		 2023-05-15
4:30 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 949 $9.872 $9,369 106,610
(Direct)		 View
2023-03-03
Sale		 2023-03-06
4:30 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 184 $8.89 $1,636 202,059
(Direct)		 View
2023-02-13
Sale		 2023-02-15
4:30 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 4,287 $9.6653 $41,435 76,243
(Direct)		 View
2023-01-10
Sale		 2023-01-12
4:30 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 1,752 $8.1601 $14,296 80,530
(Direct)		 View
2022-12-05
Sale		 2022-12-06
4:30 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 193 $10.23 $1,974 82,282
(Direct)		 View
2022-09-06
Sale		 2022-09-08
4:30 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 192 $15.01 $2,882 82,475
(Direct)		 View
2022-06-03
Sale		 2022-06-06
4:45 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 1,527 $11.54 $17,617 82,667
(Direct)		 View
2022-03-03
Sale		 2022-03-07
4:15 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 767 $17.33 $13,290 84,194
(Direct)		 View
2022-01-11
Sale		 2022-01-13
4:17 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 1,744 $25.7 $44,821 31,462
(Direct)		 View
2021-08-09
Sale		 2021-08-10
4:33 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 2,500 $60 $150,000 143,735
(Direct)		 View
2021-06-28
Sale		 2021-06-30
4:11 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 2,500 $50 $125,000 146,235
(Direct)		 View
2021-01-12
Sale		 2021-01-13
4:11 pm		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 1,568 $78.27 $122,727 18,432
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2025-02-18
Option Award		 2025-02-20
4:05 pm		 N/A
2035-02-17		 GERON CORP GERN ROBERTSON MICHELLE
EVP, Chief Financial Officer		 766,000 $0 766,000
(Direct)		 View
2024-06-18
Option Award		 2024-06-20
8:31 pm		 N/A
2034-06-18		 Verastem Inc. VSTM ROBERTSON MICHELLE
Director		 20,833 $0 20,833
(Direct)		 View
2024-06-06
Option Award		 2024-06-07
4:10 pm		 N/A
2033-09-24		 GERON CORP GERN ROBERTSON MICHELLE
EVP, Chief Financial Officer		 250,000 $0 250,000
(Direct)		 View
2024-03-11
Option Award		 2024-03-13
6:10 pm		 N/A
2034-03-11		 Verastem Inc. VSTM ROBERTSON MICHELLE
Director		 5,291 $0 5,291
(Direct)		 View
2024-02-14
Option Award		 2024-02-16
4:08 pm		 N/A
2034-02-13		 GERON CORP GERN ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 850,000 $0 850,000
(Direct)		 View
2023-09-25
Option Award		 2023-09-27
7:31 pm		 N/A
2033-09-24		 GERON CORP GERN ROBERTSON MICHELLE
EVP, Chief Financial Officer		 1,350,000 $0 1,350,000
(Direct)		 View
2023-05-15
Option Award		 2023-05-16
4:32 pm		 N/A
2033-05-15		 Verastem Inc. VSTM ROBERTSON MICHELLE
Director		 62,500 $0 62,500
(Direct)		 View
2023-03-02
Option Award		 2023-03-06
4:30 pm		 N/A
2033-03-01		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER		 126,000 $0 202,059
(Direct)		 View
2022-05-12
Option Award(A)		 2022-12-20
4:08 pm		 N/A
2032-05-12		 Verastem Inc. VSTM ROBERTSON MICHELLE
Director		 62,500 $0 62,500
(Direct)		 View
2022-06-22
Option Award		 2022-06-24
4:09 pm		 N/A
2032-06-22		 Verastem Inc. VSTM ROBERTSON MICHELLE
Director		 62,500 $0 62,500
(Direct)		 View
2022-02-10
Option Award		 2022-02-11
4:20 pm		 N/A
2032-02-09		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
CHIEF FINANCIAL OFFICER		 211,079 $0 242,541
(Direct)		 View
2021-12-22
Option Award		 2021-12-23
4:09 pm		 N/A
N/A		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 4,471 $0 33,206
(Direct)		 View
2021-11-15
Option Award		 2021-11-17
06:10 am		 N/A
2031-11-15		 Verastem Inc. VSTM ROBERTSON MICHELLE
Director		 63,493 $0 63,493
(Direct)		 View
2021-08-09
Exercise		 2021-08-10
4:33 pm		 N/A
N/A		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 2,500 $30.65 143,735
(Direct)		 View
2021-08-09
Exercise		 2021-08-10
4:33 pm		 N/A
2030-01-08		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 2,500 $0 143,735
(Direct)		 View
2021-06-28
Exercise		 2021-06-30
4:11 pm		 N/A
N/A		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 2,500 $30.65 146,235
(Direct)		 View
2021-06-28
Exercise		 2021-06-30
4:11 pm		 N/A
2030-01-08		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 2,500 $0 146,235
(Direct)		 View
2021-03-02
Option Award		 2021-03-04
4:19 pm		 N/A
2031-03-01		 Editas Medicine Inc. EDIT ROBERTSON MICHELLE
Chief Financial Officer		 42,500 $0 60,932
(Direct)		 View
(A) Indicate amendment filing.